Search

everythinglearnresearchcommunity

for

Search:↓

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

New treatments like nanotechnology show promise in improving skin cancer therapy.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Anthocyanins from fruits and vegetables may help prevent and treat colorectal cancer safely.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.